The written content of this publication may have been correct at the time it was published and is a record of what has happened in the past. The content does not reflect what has happened in the present. Request editorial corrections: firstname.lastname@example.org
New Zealand's medicines regulator, Medsafe, approved the Janssen Covid-19 Vaccine on Wednesday.
The Vaccine was given provisional approval by the regulator, which is developed by Janssen — the pharmaceutical unit of Johnson & Johnson.
It will be for use in individuals from 18 years of age and older.
Once provisional approval is given, advice from Ministry of Health officials will then be sent to the Government, who will make decisions around its use.
The Vaccine is safe and effective and will be used as a plan B in certain circumstances if, by chance, Pfizer/BioNTech runs out of stock or has a production issue.
Approval went to Medsafe in April, but additional data was sought as a precaution.
This publication was free for you to read. Each publication takes lengths of time to make, gather genuine sourced knowledge and information from official sources. Quality over quantity is not free to produce.
If you've read this publication and thought or considered supporting more from independetly owned news outlet thisquality based in Aotearoa New Zealand, it is greater than ever and much appreciated.
It only takes a minute...★ No advertisements if your contribution is $12/ᵐᵒ or more